Increasing National Impact and Uptake of Good Participatory Practice Guidelines for Biomedical HIV Prevention (GPP): Three Country Case Studies

GPP provides a systematic framework for stakeholder engagement. This infographic examines how GPP was applied to the national trial oversight process in three countries: Uganda, Thailand, and South Africa. The timline plots key GPP activities and milestones from 2011-2014. This poster was presented at the 2014 HIV Research for Prevention conference in South Africa.

Data Watch: Closing a Persistent Gap in the AIDS Response

In this update to the 2012 Action Agenda to End AIDS, amfAR and AVAC argue that critical and expensive decisions made with incomplete data can undermine the response to the AIDS epidemic—even as the systems for collecting these data continue to improve. The report describes the issues and identifies critical areas where better, more complete data are needed to guide the key decisions for the response to the HIV/AIDS epidemic. It also provides an update on prevention and treatment targets set in the Action Agenda.

Creating a Prevention Agenda for Women: AVAC/CHANGE meeting for coordinated global advocacy

This report, released by CHANGE and cosponsored by AVAC, summarizes the key recommendations related to integration of HIV and family planning services, how to best move forward in the context of uncertainty about whether some hormonal contraceptives (HC) increase HIV risk, and how to advance “method mix”—a wider array of contraceptive choices for women everywhere.

Stakeholder Engagement Toolkit for HIV Prevention Trials

The Stakeholder Engagement Toolkit for HIV Prevention Trials, developed by FHI360, is a guide to engaging a wide range of key stakeholders throughout the trial lifecycle. The toolkit is based on best practices and experience of clinical trial experts and community-based advocates. It includes short case studies, tools to guide and chart progress during a trial, stakeholder identification tools and other useful documents to document work tasks and define successful engagement in terms of the local context. 

African Women’s Civil Society Consultation on HIV Risk and Hormonal Contraceptives

More than 40 women representing HIV prevention advocates, reproductive health service providers, and women living with HIV from Kenya, South Africa, Rwanda, Uganda and Zimbabwe met to review and discuss the existing data on hormonal contraceptive use and HIV risk.

PrEP Primer (Chinese)

This document, developed by 2012 AVAC Advocacy Fellow Cai Lingping, provides background information on pre-exposure prophylaxis, reviews the evidence base and planned trials, and discusses key issues for Chinese advocates. It explores implementation challenges and the funding landscape for continued research.

Press Statement from Kenya AIDS Civil Society AIDS Groups Cheer First Major New Commitment by Presidential Candidate

This press release from a coalition of Kenyan civil society groups celebrates a success in an election-year campaign led by 2013 AVAC Advocacy Fellow Maureen Milanga to secure commitments to good HIV policy by political candidates. The pledge by Prime Minister Raila Odinga committed his administration, if elected, to provide universal access to antiretroviral therapy and to spend 15 percent of the national budget on healthcare.

Online CHAIN MSM Survey: Willingness and influencing factors for usage of PrEP among MSM

This study of 760 men who have sex with men in China, conducted by 2013 AVAC Advocacy Fellow Cai Lingping, finds high acceptability of pre-exposure prophylaxis. The survey also assessed how well informed respondents were about PrEP and examined factors that would make them more or less willing to take it.

HIV Civil Society Recommendations for Kenya’s New Health Secretary and Global Fund Application

This letter, written by a civil society coalition co-led by 2013 AVAC Advocacy Fellow Maureen Milanga, summarizes concerns and demands related to Kenya’s 2013 application to the Global Fund. The letter was sent during the Global Fund’s transition to its New Funding Model and includes guidance to the Government of Kenya on how to navigate the new system to secure support for ambitious treatment scale-up in the wake of new WHO treatment guidelines.

Ugandan Service Provider Perspectives on the WHO Recommendation on Hormonal Contraceptives and HIV Risk

This abstract poster, developed by 2012 AVAC Advocacy Fellow Lydia Mulwanyi-Mukombe and her Host, Lillian Mworeko, describes key findings from consultations with Uganda service providers. It reports how providers were planning to use the new WHO guidance and makes recommendations for how to protect and inform women in light of the potential HIV risk associated with hormonal contraceptive use.